AMLX
Amylyx Pharmaceuticals Inc
29.50$
-2.2%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| – | -54.4% | -56.2% | +7,700.0% | +1,612.9% | -77.1% | -100.0% | |
| – | +106.7% | -99.8% | +5,655.8% | +750.0% | +65.7% | -98.8% | |
| – | – | – | +6,649.8% | +1,747.2% | -87.3% | -101.2% | |
| – | +106.7% | +79.1% | +112.2% | +37.2% | -18.8% | -13.1% | |
| – | +382.3% | +162.0% | +226.5% | +40.7% | -37.6% | -43.7% | |
| – | +11.1% | +449.0% | +166.8% | +43.5% | +13.7% | -57.6% | |
| – | – | – | – | – | -911.1% | – | |
| – | +79.3% | -98.4% | +11,819.4% | – | – | – | |
| – | – | – | – | – | -656.5% | – | |
| – | +132.5% | -102.0% | – | +549.4% | -107.8% | – | |
| – | – | – | – | – | -712.4% | – | |
| – | -3,601.3% | – | – | – | -625.4% | – |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.